After a slow start, Pfizer Inc., its partner BioNTech SE and
Moderna Inc. have raised output by gaining experience, scaling up
production lines and taking other steps like making certain raw
materials on their own. Pfizer figured out how to stretch scarce
supplies of special filters needed for the vaccine production
process by recycling them. Moderna shortened the time it needed to
inspect and package newly manufactured vials of its vaccine. […]
The increased output should be enough to fully vaccinate 76
million people in the U.S. in March, another 75 million in April
and then 89 million more in May, according to estimates from
Evercore ISI analysts. The Pfizer-BioNTech and Moderna vaccines
require two doses.
By midsummer, 75% of Americans 12 years old and above should be
vaccinated, according to Morgan Stanley.
Outstanding news all around. This sort of large-scale industrial effort — both to manufacture the vaccines and get them into arms — exemplifies the U.S. at its best. Sign up and get vaccinated as soon as you can.